Zentalis Pharmaceuticals (ZNTL) Prepaid Assets (2019 - 2026)
Zentalis Pharmaceuticals (ZNTL) posted quarterly Prepaid Assets of $6.3 million for Q1 2026, down 53.97% year-over-year from $13.8 million in Q1 2025, and down 13.15% quarter-over-quarter from $7.3 million in Q4 2025.
Zentalis Pharmaceuticals (ZNTL) Prepaid Assets (2019 - 2026) Analysis & Trends
Zentalis Pharmaceuticals' Prepaid Assets history runs 8 years deep, the most recent figure standing at $6.3 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 53.97% year-over-year to $6.3 million; the TTM figure through Mar 2026 stood at $6.3 million (down 53.97% YoY), while the FY2025 annual figure was $7.3 million, down 26.89% from the prior year.
- Prepaid Assets for Q1 2026 stood at $6.3 million, down from $7.3 million in the prior quarter.
- The five-year high for Prepaid Assets was $27.2 million in Q1 2023, with the low at $6.3 million in Q1 2026.
- The 5-year median for Prepaid Assets is $12.2 million (2022), against an average of $13.8 million.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets soared 107.65% in 2022, then tumbled 59.31% in 2025.
- Zentalis Pharmaceuticals' Prepaid Assets stood at $14.6 million in 2022, then surged by 41.58% to $20.6 million in 2023, then sank by 51.58% to $10.0 million in 2024, then fell by 26.89% to $7.3 million in 2025, then declined by 13.15% to $6.3 million in 2026.
- Business Quant data shows ZNTL's Prepaid Assets at $6.3 million in Q1 2026, $7.3 million in Q4 2025, and $7.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Zentalis Pharmaceuticals | 255.14 Mn | 255.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.80 Mn |
| Mar 31, 2026 | 6.34 Mn |
| Dec 31, 2025 | 7.30 Mn |
| Sep 30, 2025 | 7.61 Mn |
| Jun 30, 2025 | 8.17 Mn |
| Mar 31, 2025 | 13.77 Mn |
| Dec 31, 2024 | 9.98 Mn |
| Sep 30, 2024 | 9.02 Mn |
| Jun 30, 2024 | 20.07 Mn |
| Mar 31, 2024 | 21.67 Mn |
| Dec 31, 2023 | 20.62 Mn |
| Sep 30, 2023 | 11.63 Mn |
| Jun 30, 2023 | 10.94 Mn |
| Mar 31, 2023 | 27.20 Mn |
| Dec 31, 2022 | 14.56 Mn |
| Sep 30, 2022 | 12.16 Mn |
| Jun 30, 2022 | 12.41 Mn |
| Mar 31, 2022 | 21.83 Mn |
| Dec 31, 2021 | 17.68 Mn |
| Sep 30, 2021 | 16.47 Mn |